Cargando…
KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer
BACKGROUND: We previously reported that loss of KRAS mutations (“regressive” mutational trajectories) from primary tumors to metastases associated with the oligo-metastatic status in colorectal cancer (CRC). The present study was undertaken in order to analyze the mutational trajectories of KRAS in...
Autores principales: | Ottaiano, Alessandro, Nasti, Guglielmo, Santorsola, Mariachiara, Altieri, Vincenzo, Di Fruscio, Giuseppina, Circelli, Luisa, Luce, Amalia, Cossu, Alessia Maria, Scognamiglio, Giosuè, Perri, Francesco, Correra, Marco, Belli, Andrea, Delrio, Paolo, Botti, Gerardo, Caraglia, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039443/ https://www.ncbi.nlm.nih.gov/pubmed/33854968 http://dx.doi.org/10.3389/fonc.2021.632962 |
Ejemplares similares
-
Genetic regressive trajectories in colorectal cancer: A new hallmark of oligo-metastatic disease?
por: Ottaiano, Alessandro, et al.
Publicado: (2021) -
Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2020) -
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives
por: Ottaiano, Alessandro, et al.
Publicado: (2023) -
Characterization of KRAS Mutational Regression in Oligometastatic Patients
por: Ottaiano, Alessandro, et al.
Publicado: (2022) -
KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies
por: Ottaiano, Alessandro, et al.
Publicado: (2023)